COVID-19 Associated With Psoriasis

A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

NCT03236870 ·Status: COMPLETED

Characterization of the Fungal Immunopeptidome Involved in the Immunopathological Mechanisms of Psoriasis

NCT06610942 ·Status: NOT_YET_RECRUITING

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis

NCT06109818 ·Status: COMPLETED ·Phase: PHASE2

Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis

NCT01122095 ·Status: UNKNOWN

AsseSSing Impact in pSoriatic Treatment

NCT05171270 ·Status: COMPLETED

Analysis Of The Influence Of Metabolic Syndrome On Treatment Efficacy With Anti-Tnf In Moderate-Severe Psoriasis In Real Clinical Practice.

NCT01753245 ·Status: UNKNOWN

Interleukin 38 as a Biomarker for Metabolic Syndrome in Psoriatic Patients

NCT05076812 ·Status: UNKNOWN

The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis

NCT01504113 ·Status: UNKNOWN

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

NCT06842199 ·Status: RECRUITING ·Phase: PHASE3

The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

NCT01971346 ·Status: COMPLETED ·Phase: PHASE4

Hypertension, Antihypertensive Medication Use, and Risk of Psoriasis

NCT06075394 ·Status: COMPLETED

An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis

NCT01555606 ·Status: COMPLETED

A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis

NCT05120297 ·Status: COMPLETED ·Phase: PHASE3

A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China

NCT06512337 ·Status: ACTIVE_NOT_RECRUITING

A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan

NCT05633264 ·Status: COMPLETED

Immunoclassification of Psoriasis: a Strategy for Precision Medicine

NCT05503875 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

NCT05730725 ·Status: COMPLETED ·Phase: PHASE2

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

NCT01522742 ·Status: TERMINATED

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

NCT00162253 ·Status: TERMINATED ·Phase: PHASE2

Immune Spatial Features of Guselkumab Cutaneous Response

NCT05858632 ·Status: RECRUITING ·Phase: PHASE4

A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis

NCT05547490 ·Status: COMPLETED

Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

NCT05863273 ·Status: COMPLETED

A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants

NCT04316585 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China

NCT04894890 ·Status: COMPLETED